Natural Products New Zealand An overview
Transcription
Natural Products New Zealand An overview
Natural Products New Zealand An overview Peter Lehrke Director, Natural Products NZ January 2016 NPNZ • We are the industry association in NZ for natural products including dietary supplements and skincare plus more • We represent over 80% of the industry • $1.4bn contribution to economy (+40%) • 70% of NZ export earnings are from biologically based industries NPNZ Mission Statement To increase the profile of New Zealand as a source of quality natural products and to foster the development of a sustainable natural products sector through collaboration Represent our industry to the legislators Act as the voice of the industry – with positive messaging and appropriate comment on negative reports Work with the industry to assist export and achieve growth Niche Products for Export Foods For Health Peter Lehrke Product Development Consultant www.pharmatech.co.nz Objectives: • The story of colostrum as a niche export • Health benefits of colostrum • Colostrum marketing challenges • Opportunities and dangers • Risk Mitigation What is colostrum? • First milk, produced by the mammary gland by all mammals after birth • Nutrition for neonates – passive immunity • Thick cream coloured milky liquid • Until 1980’s it was deemed a low value stock food • More produced than needed by calf • How could this be utilised? How can this be a health food? • Classified as a food, but “pharma” properties • Rich source of: – Antibodies (IgG) – Growth factors – Peptides – Bioactive carbohydrates • Anecdotal evidence of efficacy in humans – Immunity, gut health, sports performance – Science started to be collected on colostrum Substantial published scientific study on colostrum • PUBMED (June 2013) – 7116 hits for “colostrum” • PUBMED (Jan 2016) – 7768 hits for “colostrum” Focused mainly on the areas of: • Immunity - antibodies • Gut health – immune and growth factors • Diabetes – type 2 • Weight management – lean muscle mass • Sports performance – endurance, training Bioactives reduce each hour after calving 120 115 110 IgG in colostrum (mg/ml) 105 100 95 90 85 80 75 70 0 2 4 6 8 Hours after calving 10 12 14 There is a lot of good science in the Journals Effect of heat stress Intestinal villus height Playford et al. 1999. Gut Prosser, Stelwagen et al 2004. J. Appl. Physiol. Intestinal permeability Playford et al. 2001. Clin. Sci. But……. Internet claims for colostrum include: • Antiviral / antifungal / antibacterial / antioxidant • Eliminates viruses, bacteria and pathogens • Increases Growth Factors / Enhances Lean Muscle Mass • Regulates Cholesterol Levels / aids digestion and bowel function • Enhances the Immune System / protects against pathogens And……. Weight loss / Diabetes / Fibromyalgia / Multiple sclerosis / rheumatoid arthritis / Alleviates diarrhea / accelerates healing What is credible and what is not? Health Benefits of bovine colostrum • Influenza prevention • Reduced incidence of URTIs • Treatment & prevention of diarrhoea • Treatment of ulcerative distal colitis • Protective effect on GIT lining Bovine colostrum bioavailability • Common question: can colostrum survive the GIT (acid digestion)? • Kelly3 and Roos4 both demonstrated antibody survival through the GIT • Faecal stool measurements showed between 4-19% of active immunoglobulins • Colostrum antibodies do survive the entire length of the GIT Influenza prevention • Study in 2007 found colostrum to be 3 times more effective than ‘flu vaccine5 • 4 groups – control, vaccinated, colostrum (400mg/daily) and colostrum + vaccination • ‘Flu episodes after 3 months, respectively: 41, 57, 13 and 14 Upper respiratory tract infection prevention • Colostrum reduces the incidence of URTI in healthy children & adults6, 7 • PRIDE study7 in India investigated effect of colostrum (up to 3g/day) in 605 children with recurrent URTIs – a common & major cause of morbidity • After 3 months URTI episodes reduced by 91.2% • Important considering antibiotic resistance Diarrhoea • Diarrhoea is a major cause of death in children <5yrs in developing countries • Colostrum is beneficial for the treatment of infectious diarrhoea and recurrent diarrhoea associated with antibiotic treatment & overuse7 • Indian PRIDE study found 3 months of colostrum supplementation reduced diarrhoeal episodes by 86.6% Gastro-intestinal Health • Treatment of ulcerative colitis • When colostrum was administered via enema there was a significant reduction in the mean symptom score compared to the control group • Colostrum group histological score improved in 62.5% of subjects8 Gastro-intestinal Health • Mitigates the effects of common drugs on intestinal epithelial surface (Playford) • Chronic administration of NSAIDs can result in gastric & intestinal damage and increased intestinal permeability3, 7, 9 • Colostrum administered with indomethacin resulted in no significant increase in intestinal permeability • Group without colostrum had significant increased intestinal permeability 9 Colostrum market - 2011 Value to New Zealand economy Colostrum spray dried powder manufacture Raw material wholesale price (2011) Wholesale raw material market size 500 tonne $65,000 / tonne $32.5 million Most is incorporated into health foods and supplements Add costs of formulation, manufacture, packing, marketing, distribution Using and average scale up factor of x5 from raw material cost to retail price Total market value (2011) $125 million Most of this was export revenue, and 70% to China Some New Zealand Brands Impact of China Media 2012 In 2012 China ministry of health put out a confusing announcement Intention – to clarify that colostrum is not an approved ingredient for infant formula Result – media speculation that colostrum is harmful to infants • “Colostrum banned” • “Colostrum is abnormal milk” • “Colostrum can cause baby big head” Resulted in sales of colostrum in China to drop substantially In 2013 Fonterra stopped selling colostrum powder Now we have a shortfall Despite the China crash there is still good demand for colostrum Short fall in supply taken up by USA colostrum manufacturers Now we IMPORT most of the colostrum powder going into NZ brands Premium price is paid for good quality New Zealand colostrum: • Quality is high • Pasture grazed cows • New Zealand’s reputation for dairy and for health foods • Providence – source is important • Great opportunity for Taranaki However …....... The past has taught us a few things: 1. 2. 3. 4. 5. 6. 7. 8. 9. New Zealand origin is an important value driver Providence – provide evidence of the province Good science needs to be marketed well Quality is product value – differentiation is market value Management of supply chain is critical Innovate or die Danger is the brother of opportunity When things go pear shaped – hang in there Risk mitigation strategy is essential Other Taranaki Opportunities Other specialised dairy – Tatua example Organics Goats milk / sheep milk Specialty cheeses Boutique breweries and vineyards Skincare and cosmetics Nutraceuticals and supplements www.meno-me.co.nz EstroG-100 Dietary supplement Web based e-commerce Website developed by Kiwa Digital marketing – Apex Digital Distribution – from Taranaki Changing Regulatory Environment • • • • • • The New Zealand Natural Health Products Bill New regulatory scheme for low risk natural health products Many Dietary Supplements will fall into this category Final Consultation – closes 5th February Permitted substances list open for comment until 31 May Expected to take effect from June 2016 Visit Medsafe website for more information: Sources: http://tinyurl.com/z5mbn8e http://tinyurl.com/hnq67j3 Risk Management Good Manufacturing Practice Personnel, Premises, Equipment, Production process, Materials, Quality Control Risk Assessment Establish the objective (quality, health, safety, environment, financial…) Identify hazards (things that threaten achievement of the objective) Determine consequence & likelihood Assess the risk Options Compare current risk against acceptable risk (safe) Decide which controls are appropriate Outputs Inform business planning processes e.g. budget, project schedule… May also be required for compliance with regulatory or other standards Further information or assistance Kevin Lehrke: 027376966 or email [email protected] NPNZ Summit 2016 Into the Future The Rutherford Hotel, Nelson 16 – 18 March The Age of Disruption is here! The technological, social, demographic, economic and legislative landscapes in which we operate are constantly changing, so don’t wait for things to return to normal because this is the new normal. Early bird rate ends 29 January: $525 members / $725 non-members More information and to Register: www.naturalproductsnz.org/summit-2016 Thank You Peter Lehrke – Product Development Consultant www.pharmatech.co.nz 1. Pakken R et al. Review paper: ‘Growth Factors and Antimicrobial Factors of Bovine Colostrum’, International Dairy Journal, 1997; 7:285-297 2. Mehra R et al. Review: ‘Milk, immunoglobulins for health promotion’, International Dairy Journal, 2006 3. Kelly CP et al. ‘Survival of anti-Clostridium difficlile boving immunoglobulin concentrate in the human gastrointestinal tract’, Antimicrobial Agents and Chemotherapy, 1997; 41:236-241 4. Roos N et al. ’15N-labelled immunoglobulins from bovine colostrum are partially resistant to digestion in the human intestine’, Journal of Nutrition, 1995; 125:1238-1244 5. Cesarone MR et al. ‘Prevention of Influenzea Episodes with Colostrum Compared with Vaccination in Healthy and High-Risk Cardiovascular Subjects: The Epidemiologic Study in San Valentino’, Clinical and Applied Thrombosis / Hemastasis, April 2007; 13(2):130-136 6. Brinkworth GD et al. ‘Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males’, European Journal of Nutrition, 2003; 42:228-232 7. Kamlesh P et al. ‘Pedimune in Recurrent Respiratory Infection and Diarrhoea – The Indian Experience: The PRIDE Study’, Indian Journal of Pediatrics, July 2006; 73:585-591 References continued • 8. Kan Z et al. ‘Use of the ‘nutraceutical’ bovine colostrum, for the treatment of distal colitis: results from an initial study’, Alimentary Pharmacology & Therapeutics, 2002; 16:1917-1922 • 9. Playford RJ et al. ‘Co-administration of the health food supplement, bovie colostrum, reduces the acute non-steroidal anti-inflammatory drug-induces increase in intestinal permeability’ Clinical Science, 2001; 100:627-633 • 10. “Combining growth factors, stem cells, and gene therapy for the ageing brain” Behrstock, S., Svendsen CN. Ann. N.Y. Acad. Sci. 1019: 5-14 (2004) • 11. “Isolation of colony stimulating factor from human milk” Sinha, S. K., Yunis, A A. Biochem Biophys Res Commun.,114(2): 797-803(1983) • 12. Published in Science Network, Australia (11 February 2008 (Dr Mark Cregan, University of Western Australia) 13. Uruakpa, F. O. Et al. “Colostrum and its benefits – a review” Nutrition Research 22 (2002) 14. “Peptide immunotherapy”, Dr. Andrew M Keech, 2009, AKS Publishing, USA 15. The Open Nutraceutical Journal, 2013, 6, 35-44 35 Open Access “Development of a combined bovine colostrum and immune stimulatory carbohydrate nutraceutical for enhancement of endogenous stem cell activity”. Gill Webster and Peter Lehrke